BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals
24 août 2023 10h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 24, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig's PURE EP™ Platform Debuts New Automated Features in First Patient Cases
22 août 2023 08h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 22, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
[Latest] Global Fixed Mobile Convergence Market Size/Share Worth USD 11956.76 Billion by 2032 at a 13% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
10 août 2023 14h20 HE
|
Custom Market Insights
Austin, TX, USA, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Fixed Mobile Convergence Market Size, Trends and Insights By Network Convergence...
BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications
25 juil. 2023 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, July 25, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals
20 juil. 2023 07h11 HE
|
BioSig Technologies, Inc.
Westport, CT, July 20, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig Joins Webull Corporate Connect
29 juin 2023 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, June 29, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare
27 juin 2023 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, June 27, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
Foot Orthotic Insoles Market Size to Surpass USD 6.26 Billion in 2030, exhibiting a CAGR of 6.8%
22 juin 2023 07h34 HE
|
Fortune Business Insights
Pune, India, June 22, 2023 (GLOBE NEWSWIRE) -- The global foot orthotic insoles market size was USD 3.62 billion in 2022. The market is anticipated to expand from USD 3.96 billion in 2023 to USD...
CytoSorbents Announces Independent Data Safety and Monitoring Board Recommends Completion of the Pivotal STAR-T Trial Without Modifications Following Second Scheduled Safety Review
15 juin 2023 07h00 HE
|
CytoSorbents
PRINCETON, N.J., June 15, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
BioSig to Highlight New Data from the PURE EP™ Platform at Heart Rhythm 2023
03 mai 2023 09h00 HE
|
BioSig Technologies, Inc.
Westport, CT, May 03, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...